Fundraising Fox
ShangBay Capital LLC
Venture capitalPalo Alto · Seed–Series A · 11 people tracked
Find your way into ShangBay Capital LLC
Each arrow is one introduction. Sign up to fill in the first one.
Ask Mudit K. Jain to introduce you to William Dai
You →Mudit · together at Boston Scientific →William
Ask Jamie Chen to introduce you to Erik T. Engelson
You →Jamie · together at Lucira Health →Erik
Ask Sam Okafor to introduce you to Chaucer Shen
You →Sam · together at ShangBay Capital LLC →Chaucer
- Michael Wallace2 people can intro you
- Yajun Xu, Ph.D.2 people can intro you
- Nora Wu2 people can intro you
Sign up to find every way you can get introduced to ShangBay Capital LLC
- Your email: who you already know at ShangBay Capital LLC, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ShangBay Capital LLC team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
ShangBay Capital focuses on backing founders who build disruptive companies targeting large, unmet clinical needs through novel approaches. The firm cultivates relationships with investors, entrepreneurs, KOLs, strategics, and industry innovators, and leverages a leadership team with a combined 100+ years of experience and deep ties to strategics and innovators in disruptive technologies. Its aim is to help founders address significant market needs while generating favorable returns.
Source: firm website, verified Sep 29, 2026.
Team · 11 people
from the firm's website & public directories
What they invest in
from 55 of 71 portfolio companiesHealthtech ×42Medical Devices ×39Biotech ×26Deep Tech ×12Hardware ×10Digital Health ×9AI & Machine Learning ×6Robotics ×3
HQs:United States×43Canada×1China×1Germany×1Israel×1New Zealand×1
Who they back
founder profiles across 35 portfolio companiesFounding team size:solo founder×192 founders×123 founders×4
Where their founders studiedfrom 25 founders with education data
Stanford University ×4California Polytechnic State University-San Luis Obispo ×2Harvard University ×2Pepperdine University ×2Stanford University Graduate School of Business ×2UCLA ×2University of California, Berkeley ×2
What their founders studiedfrom 25 founders with field-of-study data
Engineering ×14Medicine ×5Business & Management ×4Life Sciences ×4Computer Science ×3Chemistry ×2Finance & Accounting ×2Physics ×2
Where their founders worked beforefrom 26 founders with career history
Align Technology ×2
Accelerator rootsportfolio companies that came through a program
11 founders hold a PhD · 8 hold an MBA (of 26 with degree data)
Investments · 71 tracked
founders shown can be your intro pathBy year:2026 · 32025 · 22024 · 42023 · 32021 · 22020 · 32019 · 32018 · 22016 · 22014 · 125 dated
Ceribell is a medical technology company that develops products for detecting and monitoring seizures, including EEG-based diagnostic systems.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSunnyvale, US
Josef Parvizi(Director)inXingjuan (Jane) Chao(President, CEO, Co-Founder & Director)inScott Blumberg(Executive Officer)inJoseph Taylor(Director)Raymond Woo(Executive Officer)David Stoffel(Executive Officer)
Co-investorsLongitude CapitalRA CapitalRed Tree VentureThe Rise Fund
Tvardi Therapeutics is a clinical-stage biopharmaceutical company developing oral small molecule STAT3 inhibitors to treat inflammatory and proliferative diseases.
BiotechHealthtechHouston, US
David J. Tweardy(Executive Officer, Director)Josef Schoell(Executive Officer)inJoseph W. Stauffer(Executive Officer)Derek Chalmers(Executive Officer, Director)inMichael E. Lewis(Executive Officer)inFrederique Menzaghi(Executive Officer)
Co-investorsSolas BioVentures
Luminopia is an FDA-cleared binocular therapy for amblyopia in children aged 4-12 that uses a VR headset to stream the child's favorite TV shows as treatment, replacing traditional eye patches.
BiotechDigital HealthHealthtechMedical DevicesAspen, US
Scott Xiao(Co-Founder & CEO)inDean Travers(Co-Founder)inBrion Raymond(CBO)inDrew Mowery(VP of Commercial Strategy)inHank Wu(COO)inSunny Atwal(VP of Engineering)in
Co-investorsBantam GroupCollaborative FundGood FriendsNXT VenturesSony Ventures CorporationUS Venture Partners+1 more
Petal is developing an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted diseased tissue without incisions, heat, or trauma.
BiotechDeep TechHealthtechMedical DevicesRedwood City, US
Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Prashant Chopra(Executive Officer, Director, Promoter)
BoardFrederic Moll(Director)inRony Abovitz(Co-founding Advisor)
Co-investorsTSVCDolma VenturesK50 VenturesSonder CapitalSonder Futures
Petal Surgical develops an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted tissue via "Acoustic Liquefaction" without cutting, heat, or trauma.
Deep TechHealthtechMedical Devices
Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Prash Chopra(Founding CEO & Director)Frederic H. Moll(Director)Rony Abovitz(Co-founding Advisor)
Co-investorsTSVCHike VenturesK50 Ventures
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Founder)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesMass General Brigham Ventures+9 more
BiotechSan Carlos, US
Xiaodong Yang(President, CEO and Secretary)inOvid Trifan(Executive Officer)Amy Wong(Executive Officer)Francis Sarena(Chief Operating Officer)Frank Hsu(Chief Medical Officer)William Duke, Jr.(Chief Financial Officer)
Co-investorsEFung Capital3E Bioventures CapitalDecheng CapitalSv Tech Ventures, Inc.Virtus Inspire Ventures
Apostle develops cell-free DNA (cfDNA) extraction and purification kits for genomics and molecular biology laboratories.
BiotechHealthtechMedical DevicesMenlo Park, US
Dongliang Ge(Executive Officer, Director)Xin Guo(Director)Bo Zhang(Executive Officer, Director)
BoardWilliam Dai(Director)in
Co-investorsAmino Capital
-2.png)
Aranz Medical is a company that provides clinical research and wound care solutions, as evidenced by their collection of clinical research posters on wound assessment, management, and documentation across healthcare settings.
Digital HealthHealthtechMedical Devices
Atia Vision develops OmniVu, a modular shape-changing dual-optic intraocular lens (IOL) that uses the eye's natural accommodative mechanism to restore near, intermediate, and distance vision for cataract patients.
BiotechHardwareHealthtechMedical DevicesCampbell, US
Henry Chen(Director)Claudio Argento(Director)Mariam Maghribi(Executive Officer, Director)Amr Salahieh(Director)Casey Gordon(Director)
Co-investorsAmed VenturesThe Capital PartnershipDelos CapitalRising Tide
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Manish Vaishya, PhD(Chief Executive Officer, Co-Founder & Board Member)Jill Schiaparelli(Executive Officer, Director)inKevin Wasserstein(Director)
BoardThomas Shehab, MD(Director)
Co-investorsAngelini VenturesArboretum VenturesAsahi Kasei Corporate Venture CapitalAvestria Ventures
Berkeley Lights (now Bruker Cellular Analysis) develops the Beacon optofluidic system for single-cell functional analysis, enabling researchers to profile live single cells to discover therapeutic antibodies, interrogate T cells, identify cell therapies, and accelerate cell line development.
BiotechDeep TechHardwareEmeryville, US
Ming Wu(Director)inIgor Khandros(Executive Officer, Director)
BoardMichael Marks(Director)inLip-Bu Tan Tan(Director)Michael Moritz(Director)inWilliam Davidow(Director)
Co-investorsCelesta CapitalCota CapitalKhosla VenturesOpen Field CapitalWalden CatalystAtinum Investment Co. Ltd.+4 more
Brius (Brava) makes orthodontic teeth-straightening technology using its Independent Movers system, which it integrates with orthodontic practices.
HardwareHealthtechMedical Devices
Mehdi Peikar(Founder)in
Co-investorsCheyenne VenturesEvolution VC PartnersSand Hill AngelsTech WildcattersView Ventures
Chimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy.
BiotechHealthtech
Co-investorsSand Hill AngelsPureTech Health
CloudMedx uses machine learning, natural language understanding, and healthcare-specific fine-tuned LLMs to analyze healthcare data and generate clinical, operational, and financial insights.
AI & Machine LearningDigital HealthHealthtechPalo Alto, US
Tashfeen Suleman(Executive Officer)Sahar Arshad(Director)
Co-investorsDFJ DragonFundFundersClub
Contraline develops new contraceptive and reproductive health technologies, with a focus on male contraception.
BiotechDigital HealthMedical DevicesCharlottesville, US
Kevin Eisenfrats(Co-Founder and CEO)inJohn Herr(Co-Founder)
BoardIris Van Alderwerelt van Rosenburgh(Director)Gurdane Bhutani(Director)inMartin J Emerson(Director)Tom Thorpe(Director)
Co-investorsBiotechnology Value FundMBX CapitalAllied Venture PartnersAlumni VenturesAmboy Street VenturesAurum Venture Partners+17 more
CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders.
B2B MarketplacesHealthtechSaaSBerlin, DE
Manuel Aberle(Founder)in
Co-investorsAbstract VenturesArtis VenturesFJ LabsJ12 VenturesStella CapitalAccel+23 more
Devoro Medical developed the WOLF Thrombectomy Platform, a non-console, lytic-free medical device that uses finger-like prongs to capture and remove blood clots (thrombi) from the arterial and venous systems.
HardwareHealthtechMedical DevicesFremont, US
BoardErik Engelson(Director)Michael Wallace(Executive Officer, Director)Skott Greenhalgh(Director)
Co-investorsAPERTURE Venture PartnersNorwest Venture Partners
Emboline develops the Emboliner Embolic Protection System, a cerebral protection device aimed at preventing stroke during transcatheter aortic valve replacement (TAVR) procedures.
HardwareHealthtechMedical DevicesSanta Cruz, US
Amir Belson(Founder & Chief Technology Officer)inMark Caires(Chief Financial Officer)inNicholas Pappas(Director)Elton Satusky(Executive Officer)Eric Xiao(Director)J. Casey McGlynn(Executive Officer)
Co-investorsAnthro VenturesTrinity Capital
Epimab Biotherapeutics is a clinical-stage biopharmaceutical company specializing in the development of bispecific antibodies using proprietary technology platforms including FIT-Ig® and MAT-Fab.
BiotechHealthtechMedical DevicesShanghai, CN
Wu Chenbing(Founder/Expert)
Co-investorsDecheng CapitalTCG Labs3E Bioventures CapitalSherpa Healthcare Partners
FemDx Medsystems is a medical device company developing minimally invasive technologies for diagnosing and treating gynecological conditions, with a focus on reproductive health and gynecological cancers.
FemTechHealthtechMedical Devices
Co-investorsPortfoliaSv Tech Ventures, Inc.
Flare Therapeutics develops small molecule medicines targeting transcription factors using a chemistry and proteomics platform that enables ligand discovery directly from cells.
AI & Machine LearningBiotechDeep TechHealthtech
Jim Audia(Executive Vice President, Drug Discovery and Early Development, and Founding Scientist)Jacob Stuckey(Senior Director, Biochemistry and Chemical Biology, and Founding Scientist)in
Co-investorsNexTech VenturesPfizer VenturesThird Rock VenturesNextech InvestPfizer Venture InvestmentsAgent Capital
Fluid Biomed develops a bioresorbable polymer-based stent designed to treat brain aneurysms by diverting blood flow and reducing risk of stroke.
BiotechDeep TechHealthtechMedical DevicesCalgary, CA
Dr. John H. Wong(Co-founder & Chief Executive Officer)Dr. Alim P. Mitha(Co-founder, President & Chief Technology Officer)
Co-investorsAccelerate FundLifeArc VenturesThin Air LabsUCeed FundsAmplitude Venture CapitalIAG Capital Partners
IgGenix is a clinical-stage biotechnology company focused on antibody discovery and development for allergies and immunological diseases.
AI & Machine LearningBiotechHealthtechSouth San Francisco, US
Kari Nadeau(Scientific Co-Founder)
Co-investorsKhosla VenturesAllerfund Ventures, LlcFemHealth VenturesGlobal BrainMedical Incubator Japan K.K.Alexandria+1 more
Immune Onc is a biotechnology company developing medicines to treat patients with hard-to-treat cancers and autoimmune diseases, with expertise in translational medicine and clinical development.
BiotechMedical DevicesPalo Alto, US
Xiaoling Charlene Liao(Executive Officer, Director)
BoardGuo-Liang Yu(Director)Liqun Luo(Director)
Co-investorsCLI VenturesNorthern Light Venture CapitalVivo CapitalTriWise Capital
Inquis Medical is a medical device company developing minimally invasive technology to treat thromboembolic disease in the cardiovascular and vascular space.
Deep TechHardwareHealthtechMedical DevicesMenlo Park, US
Vahid Saadat(CEO)inMojgan Saadat(Co-founder)in
BoardDavid A. Lamond(Chairperson of the Board)
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation.
HealthtechMedical DevicesPlymouth, US
Ramji Iyer(Executive Officer, Director)in
BoardJenny H. Barba(Director)Todd Mortier(Director)Colin Morrison(Director)
Co-investorsAphelion CapitalFeatures Capital Holdingsgener8torUnorthodox VenturesAphelion CardeationEngage Venture Partners
Lucira Health manufactures portable diagnostic devices that connect to smartphones to test bodily fluids for infectious diseases, enabling rapid results outside of clinical settings.
BiotechHealthtechMedical DevicesEmeryville, US
Debkishore Mitra(Founder)inJohn R. Waldeisen(Director)
BoardErik T. Engelson(Executive Officer, Director)Justin Butler(Director)Tuff Yen(Director)Steve Tablak(Director)
Co-investors11.2 CapitalForesite CapitalY CombinatorDCVC (Data Collective)DHVCEclipse Ventures+5 more
Magnetic Particle Imaging (MPI) is an imaging technology that detects iron oxide nanoparticle tracers using time-varying magnetic fields to create medical images with high contrast and sensitivity.
Deep TechHealthtechMedical Devices
Co-investors5AM VenturesAlumni VenturesCloudStone CapitalEvolution VC PartnersInnolinks VenturesSand Hill Angels+2 more
Mediartx develops novel therapies for patients with fibrotic diseases.
BiotechMedical DevicesBoston, US
Rahul Ballal, PhD(CEO)Paul Yaworsky, PhD(CSO)inRahul Ballal(Executive Officer, Director)inBrian Hubbard(Director)Stacey Brenner(Executive Officer)David de Graaf(Director)
Co-investorsAgent CapitalGimvLongwood FundMission BiocapitalNovartis Venture FundOno Venture Investment, Inc.+5 more
Neptune Medical is a medical device company developing GI endoscopy products based on its Dynamic Rigidization technology, including the FDA-cleared Pathfinder endoscope and the Triton robotic endoscopy system for colon navigation.
HealthtechMedical DevicesRoboticsSilicon Valley, US
Alex Tilson(Founder & CEO)in
Co-investorsSonder CapitalInCube VenturesMighty Capital
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation.
HardwareHealthtechMedical Devices
Co-investorsFoothill VenturesJoyance PartnersLumira VenturesUS Venture PartnersAmzak HealthU.S. Venture Partners
neuro42 develops a portable, FDA 510(k)-cleared MRI platform that brings neurological imaging directly to the patient rather than requiring transport to a facility.
Deep TechHealthtechMedical DevicesSan Francisco, US
Amit Vohra(Executive Officer, Director)inAbhita Batra(Executive Officer, Director)Shibu Gangadharan(Executive Officer)
BoardKrishna R. Bhupal(Director)Rahul Talwar(Director)
Co-investorsFrontier Path VCSonder Capital
NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions.
Deep TechHealthtechMedical DevicesCalifornia, US
JIANLU MA(Executive Officer, Director)
BoardLU GANG(Director)WILLIAM DAI(Director)inJEFF PETERS(Director)DAVE FERRERA(Director)
Co-investorsSv Tech Ventures, Inc.
Noah Medical develops robotic and software solutions for diagnostic bronchoscopy procedures, designed to enable earlier lung cancer diagnosis with improved accuracy.
HealthtechMedical DevicesRoboticsSilicon Valley, US
Jian Zhang(Founder & CEO)Enrique RomoinFrank Grilloin
Co-investors1955 CapitalChina Growth CapitalLYFE CapitalProsperity7 Ventures
OrthoFX makes AirFlex, an FDA-cleared clear aligner system that straightens teeth with at least 12 hours of continuous daily wear using a patented elastic polymer for lower force.
ConsumerDigital HealthHealthtechMedical DevicesNew MaterialsFremont, US
Nichole Garcia(Founder)inRen Menon(Founder)inHenry Chan(Founder)in
Co-investorsXRCSignalFireUnusual Ventures
Petal offers credit card products aimed at helping people access credit, including those new to credit or with past credit issues, by using their savings and spending data to assess creditworthiness beyond a traditional credit score.
ConsumerFintechOxford, US
David Michael Melnick Taffet(Executive Officer)
Co-investorsAfore CapitalEvolution VC PartnersFairhaven Capital PartnersGreat Oaks Venture CapitalNat TurnerNelstone Ventures+13 more
Pykus Therapeutics is a clinical-stage medical technology company developing biodegradable polymers for vitreoretinal surgery.
BiotechHealthtechMedical DevicesCambridge, US
James (Tony) Stefater(Founder)inTony Stefater, MD, PhD(President & Cofounder)Tommy Stryjewski, MD(Chief Scientific Officer, Cofounder, Director)Michael Singer(Director)Richel Liu(Director)Thomas P. Stryjewski(Director)
Co-investorsBeacon Angels
Radiaction Medical develops a plug-and-play radiation protection device for interventional medical staff that reduces scatter radiation at the source, with FDA Class II clearance for use in the United States, European Union, and United Kingdom.
Deep TechHardwareHealthtechMedical DevicesTel Aviv, IL
Amir Belson(Founder)in
BiotechMenlo Park, US
Cuiping Gu(Director)David Parkinson(Director)inZhenping Zhu(Director)Karen Liu(Director)Bing C. Wang(Executive Officer, Director)
Co-investorsDanhua CapitalSangel CapitalWuXi Healthcare Ventures
SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.
BiotechHealthtechMedical DevicesValencia, US
Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)in
BoardBlake Wu(Director)inJuan-Pablo Mas(Director)in
Co-investorsAlly Bridge GroupNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersAsahi Kasei Corporate Venture CapitalCatalio Capital Management, LP+7 more
Skyhawk Therapeutics develops RNA-targeting small molecule drugs using its SKYSTAR platform to modify RNA expression, addressing diseases in neurology, oncology, and fibrotic conditions.
BiotechDeep TechWaltham, US
Kathleen McCarthy(Founder)
Co-investorsAgent CapitalDns CapitalGood Growth CapitalGreatPoint Ventures
Solenic Medical is a medical company; this page is an investor contact form and does not describe the company's products or technology in detail.
Medical DevicesCollege Station, US
James Y Lancaster(Executive Officer, Director)in
BoardJohn Hodock(Director)Robert Calvin Goforth(Director)
Co-investorsSugati VenturesJohnson & Johnson Innovation – JJDC
Sonovascular is developing an interventional treatment for venous thromboembolism (VTE) that uses microbubble-mediated cavitation, delivered as a cath lab-based procedure without requiring ICU treatment.
BiotechHealthtechMedical DevicesChapel Hill, US
Daniel Estay(Executive Officer, Director)inWilliam N. Starling(Director)
Co-investorsBand of AngelsWolfpack Investor Network
SoundHealth develops FDA 510(k) cleared, drug-free medical devices that use acoustic resonance therapy via forehead bone conduction to treat nasal congestion and improve sleep.
AI & Machine LearningDigital HealthMedical Devices
Paramesh Gopi, PhD(Founder & CEO)Bryant Lin, MD, MEng(Founder & Head of Clinical Affairs and Product Design)Peter Hwang, MD(Founder & Head of Research)
Co-investorsG Vision CapitalJ4 VenturesMoai CapitalTau Ventures
Sporos Bioventures is a private biotechnology company that uses a portfolio approach to drug development in oncology, holding equity stakes in biopharma entities such as Tvardi Therapeutics and Sporos BioDiscovery.
BiotechHealthtechHouston, US
Tangible Science develops contact lens solutions designed to improve comfort and durability for wearers and to provide eye care professionals with more effective treatment options.
HealthtechMedical DevicesMenlo Park, US
Karen Havenstrite(Director)inVictor McCray(Executive Officer, Director)
BoardDouglas Crawford(Director)inHanson Gifford(Director)Chip Heath(Director)Brandon Felkins(Director)
Co-investorsMission BiocapitalLightstone Ventures
Telesair develops medical devices focused on patient care, with work spanning strategy, design, engineering, and quality assurance.
AI & Machine LearningHardwareHealthtechMedical DevicesIrvine, US
Don Lin(Co-founder & CEO)inKen Wang(Executive Officer, Director)inDongping Lin(Executive Officer, Director)Matt Margolies(Executive Officer, Director)inJing Zhang(Director)Bo Li(Director)
Co-investorsDevice of Tomorrow CapitalHoneywell Ventures
Venova Medical develops the Velocity percutaneous arteriovenous fistula system, a minimally invasive medical device designed to create vascular access for hemodialysis patients more efficiently than traditional surgical methods.
HealthtechMedical DevicesLos Gatos, US
Erik van der Burg(Executive Officer, Director)in
BoardMichael Wallace(Director)inDarshana Zaveri(Director)inShant Vartanian(Director)in
Co-investorsAphelion CapitalCadence Healthcare VenturesCatalyst Health Ventures
Window Therapeutics is a biotechnology company developing therapeutics for cancer and other life-threatening diseases, based on its bottle-brush-analogue-macromonomer (BAM) technology.
BiotechDeep TechHealthtechBoston, US
James Lu(Director)Jeremiah Johnson(Founder (based on BAM technology from his MIT lab))Lusong Luo(Director)Chih-Kao Hu(Executive Officer, Director)
BoardKenneth C. Anderson(Professor, Researcher and Clinician, Harvard Medical School & DFCI)
YorLabs develops an intracardiac echocardiography (ICE) ultrasound imaging system aimed at interventional cardiology and electrophysiology procedures.
Digital HealthHardwareMedical DevicesBeaverton, US
Clark Brooks(Founder)Sunit Rikhi(Founder)
ZAP Surgical develops the ZAP-X Gyroscopic Radiosurgery platform, a self-shielded surgical robotics system for non-invasive cranial stereotactic radiosurgery (SRS) that uses linear accelerator technology instead of radioactive sources.
HealthtechMedical DevicesRobotics
John R. Adler, Jr.(Founder)
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(Founder/CTO)inNick Damiano(Executive Officer, Director)inJohn Beck(Executive Officer)in
BoardBryan Kim(Director)Robert Weisskoff(Director)inBlayne Roeder(Director)
Co-investorsAstiaCloudStone CapitalDorm RoomF-Prime CapitalY CombinatorAgrolimen Ventures+15 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AlleviantAqua MedicalArrinexCorinth MedtechEarly Bird MedicalFrond MedicalMeditrinaModular SurgicalPiezolabsPresidio MedicalQuandxRefuge BiotechRestera MedicalSentiré Medical SystemsSightStreamTioga MedicalTrueBindingZeto
Exits · 3
3 IPOs · showing 2CeribellNASDAQ: CBLLTvardi TherapeuticsNASDAQ: TVRD
Portfolio news
latest coverage across their companiesAbcuro · finsmes.com · Aug 18, 2026
Sound Health · finsmes.com · Jul 31, 2026
Flare Therapeutics · globenewswire.com · Jun 30, 2026
Nervonik · citybiz.co · Apr 28, 2026
Frequently asked questions
- How many investments has ShangBay Capital LLC made?
- ShangBay Capital LLC has 71 tracked investments, 3 of which have exited, including 7 dated in the last 24 months.
- What stage does ShangBay Capital LLC invest at?
- ShangBay Capital LLC invests at the Seed, Series A stages.
- What sectors does ShangBay Capital LLC focus on?
- ShangBay Capital LLC focuses on Biotech, Healthtech, Medical Devices.
- Where is ShangBay Capital LLC located?
- ShangBay Capital LLC is headquartered in Palo Alto, US.
- Does ShangBay Capital LLC lead rounds?
- ShangBay Capital LLC has led 3 of the 8 rounds where its role is on record.
- Who does ShangBay Capital LLC co-invest with?
- ShangBay Capital LLC most often shares deals with Evolution VC Partners, RA Capital, Sand Hill Angels, among 122 tracked co-investors.
- What size deals does ShangBay Capital LLC back?
- Across 8 deals with disclosed amounts, ShangBay Capital LLC has joined rounds of $8M – $95M (median $24.5M).
Co-investors · 7
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Amplitude Ventures is a Canadian venture capital firm that creates, builds, and grows precision medicine companies, investing in human health from ideation through patient care.
Action Potential Venture Capital is a venture firm investing in healthcare and medical technology companies.
Morgenthaler is a venture capital and private equity firm that has focused on building valuable companies for over 40 years.
Sony Innovation Fund is the corporate venture capital arm operated by Sony Ventures Corporation, investing in technology and entertainment startups worldwide.
Firms observed investing alongside ShangBay Capital LLC, from public investor directories. Shared companies are the overlap with ShangBay Capital LLC's recorded portfolio.
Similar investors
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Black Opal Ventures is a venture capital firm founded in 2021 by Tara Bishop and Eileen Tanghal, investing at the intersection of technology and healthcare.
Frist Cressey Ventures (FCV) is a venture capital firm focused on transforming healthcare and improving lives, offering portfolio companies strategic support alongside capital.
MedMountain Ventures (MMV) is a physician-led venture capital firm founded by board-certified physicians that invests early in transformative healthcare companies aiming to improve patient outcomes and reform care delivery.